Has Samuel Dower, MD received payments from drug or device companies?

Yes. Drug and device makers reported $33 in general payments to Samuel Dower, MD across 2 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Samuel Dower, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Samuel Dower, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Samuel Dower, MD

Endocrinology, Diabetes & Metabolism · Livingston, NJNPI 1942260690

Payments from drug & device makers

$33in general payments, 2019–2025

Across 2 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$33

What the payments were for

Food & beverage$33100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	2	$33

How this compares

$33 in reported general payments places this provider in the 0th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

See all endocrinology, diabetes & metabolism providers in New Jersey →

Medicare billing

Part B allowed, 2024

$611,360

Medicare patients

953

Services billed

32,850

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	374	$565,942
MounjaroTirzepatide	261	$371,644
JardianceEmpagliflozin	198	$270,190
FarxigaDapagliflozin Propanediol	164	$187,161
TradjentaLinagliptin	138	$154,624
JanumetSitagliptin Phos/Metformin Hcl	131	$152,310
TrulicityDulaglutide	76	$138,634
JanuviaSitagliptin Phosphate	95	$130,135
Tresiba Flextouch U-100Insulin Degludec	103	$80,041
Tresiba Flextouch U-200Insulin Degludec	53	$78,573
RybelsusSemaglutide	38	$77,902
SynthroidLevothyroxine Sodium	598	$63,031
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog	57	$57,180
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7	14	$31,336
Humalog Kwikpen U-200Insulin Lispro	23	$30,846

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Livingston

Sridhar NambiLivingston$86K
Barry GertzRahway$903K
Nawras MakhsidaRandolph$882K
Marc SandbergFlemington$567K
Joanne WaldstreicherNew Brunswick$441K
Gregory BaroneCherry Hill$433K
Taher ModarressiPennington$414K
Navtika DesaiHillsborough$408K
Atara SchultzTeaneck$357K
Anthony CannonTurnersville$296K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →